跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-verapamil
首页
药物
R-verapamil
R-verapamil
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of treating hyperglycemia
申请人: CENTER LABORATORIES INC
优先权: 2016
CN
US
3 件公开
Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
申请人: KELLY JOHN
优先权: 2002
US
3 件公开
Crystal forms of verapamil hydrochloride
申请人: CENTER LABORATORIES INC
优先权: 2014
CN
US
3 件公开
Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity
申请人: DEVANE JOHN
优先权: 2007
US
2 件公开
Method of treating hyperglycemia
申请人: CENTER LABORATORIES INC
优先权: 2018
US
COMPOSITIONS AND METHODS HAVING MT1 RECEPTOR ACTIVITY
申请人: AGI THERAPEUTICS RES LTD
优先权: 2008
US
AGENT FOR TREATING ATRIAL FIBRILLATION
申请人: WADA KOICHI
优先权: 2005
US
Hederagenin C-2 heterocyclic oxime ester derivative as well as preparation method and application thereof
申请人: UNIV YANTAI
优先权: 2025
CN
药物
反馈